Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Research Articles, Neurobiology of Disease

Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons

Grace I. Hallinan, Mariana Vargas-Caballero, Jonathan West and Katrin Deinhardt
Journal of Neuroscience 27 November 2019, 39 (48) 9623-9632; DOI: https://doi.org/10.1523/JNEUROSCI.1590-19.2019
Grace I. Hallinan
1Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Grace I. Hallinan
Mariana Vargas-Caballero
1Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariana Vargas-Caballero
Jonathan West
2Faculty of Medicine and Centre for Hybrid Biodevices, Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan West
Katrin Deinhardt
1Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katrin Deinhardt
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Neurofibrillary tangles, formed of misfolded, hyperphosphorylated tau protein, are a pathological hallmark of several neurodegenerations, including Alzheimer's disease. Tau pathology spreads between neurons and propagates misfolding in a prion-like manner throughout connected neuronal circuits. Tauopathy is accompanied by significant neuronal death, but the relationships between initial tau misfolding, propagation across connected neurons and cytotoxicity remain unclear. In particular the immediate functional consequence of tau misfolding for the individual neuron is not well understood. Here, using microfluidic devices to recreate discretely organized neuronal connections, we show that the spread and propagation of misfolded tau between individual murine neurons is rapid and efficient; it occurs within days. The neurons containing and propagating tau pathology display selective axonal transport deficits but remain viable and electrically competent. Therefore, we demonstrate that seed-competent misfolded tau species do not acutely cause cell death, but instead initiate discrete cellular dysfunctions.

SIGNIFICANCE STATEMENT Public awareness of progressive neurodegenerations such as dementias associated with aging or repetitive head trauma is rising. Protein misfolding underlies many neurodegenerative diseases including tauopathies, where the misfolded tau protein propagates pathology through connected brain circuits in a prion-like manner. Clinically, these diseases progress over the course of years. Here we show that the underlying protein misfolding propagates rapidly between individual neurons. Presence of misfolded tau is not directly cytotoxic to the neuron; the cells remain viable with limited deficits. This suggests that neurons with tau pathology could be rescued with a therapeutic disease modifier and highlights an under-appreciated time window for such therapeutic intervention.

  • Alzheimer's disease
  • microfluidic devices
  • prion-like propagation
  • seeding
  • tau

Introduction

Neurofibrillary tangles (NFTs), a pathological hallmark of several neurodegenerations including Alzheimer's disease (AD), consist of structured insoluble aggregates of hyperphosphorylated tau (Grundke-Iqbal et al., 1986). The neuroanatomical localization of NFTs in AD brains suggests that tau pathology propagates through the brain along anterograde connected circuits (de Calignon et al., 2012; Ahmed et al., 2014). Indeed, it is well established that pathogenic tau spreads between cells in vitro (Frost et al., 2009; Sanders et al., 2014) and in vivo (Lasagna-Reeves et al., 2012; Liu et al., 2012; de Calignon et al., 2012) in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009; Kfoury et al., 2012; Kaufman et al., 2016). Tau oligomers of hyperphosphorylated tau have been isolated from patient brains (Köpke et al., 1993) and cause hyperphosphorylation and misfolding of native tau (Alonso et al., 1996; Li et al., 2007). The tau seeds that template the misfolded conformation to native tau are monomers or lower molecular weight oligomers (Michel et al., 2014; Falcon et al., 2015; Kim et al., 2015; Mirbaha et al., 2015; Jackson et al., 2016; Sharma et al., 2018), and as tau polymerizes into filaments it loses seeding activity (Alonso et al., 2006).

Pathogenic tau causes cell death both in vivo (de Calignon et al., 2012) and in vitro (Gómez-Ramos et al., 2006; Tian et al., 2013), and advancement of AD is associated with extensive neuronal loss (Braak and Braak, 1991). Exogenous addition of tau is toxic to neurons in vitro (Gómez-Ramos et al., 2006; Kopeikina et al., 2012; Tian et al., 2013), suggesting that tau misfolding and aggregation is associated with neuronal death. Therefore, it has been suggested that tau seeds are released following the disintegration of the tangle-bearing neurons (Guo and Lee, 2011; Hu et al., 2016). This is consistent with in vivo observations where loss of neurons is progressive within brain areas affected by degeneration. Interestingly, recent studies have detected tau species capable of seeding misfolding in human brain areas free of tangle pathology (DeVos et al., 2018), implying that tau seed release occurs from intact neurons and precedes neuronal death (Pickett et al., 2017). By their nature these in vivo studies are short of the resolution required to identify the individual neurons bearing and releasing misfolded tau species, and as a consequence the physiological state of these neurons remains unclear.

To propagate pathology in a prion-like manner tau seeds spread to connected neurons and interact with native tau in the cytosol to template its misfolding. Studies using exogenous tau preparations to investigate the mechanisms underlying tau pathology transmission have shown that aggregates are internalized into primary neurons, trafficked both anterogradely and retrogradely along axons, spread to connected cells (J. W. Wu et al., 2013; Wu et al., 2016; Takeda et al., 2015; Wang et al., 2017), and propagate tau pathology (Calafate et al., 2015; Wu et al., 2016; Nobuhara et al., 2017). However, the efficiency of propagation of tau misfolding between individual neurons and the consequence for the individual neuron's physiology have not been resolved.

In this study, we created a minimalistic neuronal circuit within a compartmentalized microfluidic device to investigate tau misfolding and propagation with single cell resolution. We show that a phosphomimetic tau, tauE14, in which 14 disease-relevant serine/threonine residues have been mutated to glutamate to mimic phosphorylation (Hoover et al., 2010), misfolds within primary neurons in the absence of exogenous seeds. Misfolded tauE14 seeds template a rapid and efficient prion-like misfolding of native tau and transmit the conformational change of tau between intact, connected neurons with high efficiency. This suggests that propagation of misfolded tau occurs between live, functioning neurons in very early stages before neuronal degeneration. Our findings imply that propagation of misfolded tau through the brain likely precedes detectable symptoms, strengthening the idea that targeting the spread of misfolded tau in as yet unaffected areas may present a disease modifying approach for mild cognitive impairment.

Materials and Methods

Plasmids.

The following plasmids were used: pRFP-N1, pEGFP-C3 (Clontech); pRK5-EGFP-tauWT and pRK5-EGFP-tauE14 were a gift from Karen Ashe (Hoover et al., 2010; Addgene, plasmids #46904 and #46907); GCaMP6 was a gift from Douglas Kim (Chen et al., 2013; Addgene, plasmid #40753); and R-GECO was a gift from Robert Campbell (J. Wu et al., 2013; Addgene, plasmid #45494). RFP-tauWT and RFP-tauE14 were created by excising the GFP fragment of pRK5-EGFP-TauWT at Cla1 and BamH1 sites, and replacing it with RFP, which was amplified by PCR with forward primer 5′-CATGATCGATATGGCCTCCTCC-3′ and reverse primer 5′-CATGGGATCCGGCGCCGGT-3′.

Cell culture and transfection.

All experiments were performed in accordance with the Animals (Scientific Procedures) Act 1986 set out by the UK Home Office. Primary cultures were prepared as described previously (Deinhardt et al., 2011) from embryonic day (E)15–E18 C57BL/6 mouse hippocampus. Dissociated neurons were plated in neurobasal medium supplemented with 2% B27 and 0.5 mm GlutaMAX (Invitrogen) at a density of 7000 cells/μl in microfluidic devices and 150,000 cells/ml in glass-bottom dishes. Partial medium changes were performed on the devices every 2–3 d. At 1 DIV, neurons were transfected using Lipofectamine 2000 as described previously (Deinhardt et al., 2011). Transfection mix was added to device channels sequentially, and channels were fluidically isolated from each other through a volume difference to ensure no diffusion of the solution across channels (Dinh et al., 2013).

Microfluidic devices.

Custom microfluidic devices were manufactured based on existing designs (Taylor et al., 2003; Peyrin et al., 2011). Devices were replicated as described previously (Holloway et al., 2019), washed in 70% EtOH for 1 h and dried before use. Devices were mounted onto 22 × 55 mm coverslips (Smith Scientific) pretreated with 0.1 mg/ml poly-d-lysine (Sigma-Aldrich). Device channels were filled with supplemented neurobasal medium and incubated overnight before addition of cells.

Immunocytochemistry.

Neurons were fixed in 4% paraformaldehyde in PBS for 10–15 min, washed with 50 mm ammonium chloride in TBS for 5 min, and permeabilized in 0.1% Triton X-100 in TBS for 5 min at room temperature (RT). The cells were then blocked for 30 min in 10% goat serum in TBS at RT. Cells were incubated for 1 h at RT or overnight at 4°C in the following primary antibodies: MC1 [1:300; gift from Peter Davies (Jicha et al., 1997)], synapsin-1 (D12G5, 1:1000; Cell Signaling Technology). Primary antibody was washed off in TBS, and Hoechst (33342) was added to the second wash to stain nuclei (1:3000; ThermoFisher Scientific). This was followed by incubation for 30 min at RT with fluorescently-conjugated secondary antibodies (Invitrogen).

Microscopy.

Fixed cell images for axonal length analysis were taken on a Zeiss Axioplan Fluorescence Microscope equipped with a HBO103 Mercury lamp for illumination, a QImaging Retiga 3000 monochrome CCD camera (Photometrics), 20×/0.4 NA and 40×/0.75 NA Plan-Neofluar objectives, using Micro-manager software (Vale Lab). Fluorescent and differential interference contrast (DIC) images of cells in devices were obtained using a 60×/1.42 NA Oil Plan APO objective on a DeltaVision Elite system (GE Life Sciences) with SSI 7-band LED for illumination and a monochrome sCMOS camera, using SoftWoRks software v6. Confocal images were taken on a Leica SP8 laser scanning confocal microscope using a 63×/1.30 NA HC Pl Apo CS2 glycerol immersion objective, with a PCO Edge 5.5 sCMOS camera. Lasers used for illumination were continuous wave solid-state lasers at 405 and 561 nm, and a continuous wave argon gas laser at 488 nm.

Live cell imaging was performed on the DeltaVision Elite system (GE Life Sciences). For imaging of lysosomes, 14 DIV neurons were incubated with 25 nm LysoTracker Deep Red (ThermoFisher Scientific) for 20 min at 37°C. LysoTracker solution was then removed and replaced with supplemented neurobasal medium containing 50 mm HEPES-NaOH, pH 7.4. Images were taken at 0.2 Hz for 5 min. For calcium imaging, neurons were cotransfected with GCaMP6 and RFP-TauE14 or RFP-TauWT, or R-GECO and GFP-TauE14 or GFP-TauWT and imaged at 14 d in vitro (DIV) at 2 Hz for 6 min. After 3 min, 1 μm tetrodotoxin (Sigma-Aldrich) was added, followed after 2 min by 100 mm KCl.

Image analysis.

Overview images were reconstructed from multiple single images using Autostitch software (University of British Columbia). Images were analyzed using ImageJ software (NIH), and its plugins NeuronJ (Meijering et al., 2004) and Iterative Deconvolution (Bob Dougherty, OptiNav Inc). Axonal length was defined as the longest axonal branch from the longest neurite. Distal axon was defined as a 75 μm stretch of axon at, or near to, the terminal of an axon branch, and proximal axon was defined as a 75 μm long stretch of axon measured beyond the first 50 μm of axon protruding from the cell body, therefore, beyond the axonal initial segment. Intensity profiles along a line were generated using plot profile, and kymographs using the MultipleKymograph plugin on ImageJ. Lysosomes which displaced >50 μm over the course of the time lapse were considered moving. Aggregate analysis was performed using MATLAB.

Aggregate analysis.

The fluorescence intensity values of control and experimental axons were measured. Plot profiles of 75 μm long axonal stretches were generated from 16-bit images, and the pixel intensity values were analyzed. To assess normal fluorescence fluctuations, a selection of intensity values derived from 50 control tauWT axons across the time course were randomly chosen, and each was zeroed to its 10th percentile. The mean + 5 SD of these values was calculated as 500 arbitrary units (a.u.). Therefore, tauWT control axons with values >500 a.u. were excluded from generating experimental control means, but included in the final analysis.

The fluorescence values for at least 12 control tauWT and experimental tauE14 75 μm long axonal stretches were analyzed per time point, with three separate experiments per time point. The mean of the SDs of the control axons not excluded by the 500 a.u. cutoff was calculated. Any individual fluorescence value of tauWT or tauE14 axons lying five times outside this mean was identified to be an aggregate-containing point. The sum of the aggregate-containing points was calculated for control tauWT and experimental tauE14 axonal stretches, and from this the percentage of aggregate-containing values along an axonal stretch was calculated. Any axonal stretch that contains >10% of its fluorescence values, i.e., over cumulative 7.5 μm of the analyzed length, as aggregate-containing values was identified as axon positive for tau aggregation. This cutoff allows for intensity variations because of e.g., crossing axons to be discounted. Finally, the percentage of cells positive for tau aggregation is calculated for tauWT and tauE14-expressing neurons.

Electrophysiology.

Cells were cultured on coverslips and transfected with RFP-TauWT or RFP-TauE14. For patch-clamp recording, cells were perfused with oxygenated (95% O2, 5% CO2) artificial CSF, which contained the following (in mm): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, and 10 glucose, pH 7.3–7.4, at a rate of 1–2 ml/min. Recordings were performed under visual control. Patch pipettes (4–6 MΩ) were pulled from thick-walled borosilicate glass tubing and filled with a solution containing the following (in mm): 110 K-gluconate, 10 KCl, 10 Na-phosphocreatine, 10 HEPES, 4 ATP-Mg, 0.3 GTP, pH 7.25 adjusted with KOH; osmolarity 280 mOsm/L. Recordings were performed at room temperature using an amplifier AxoPatch 200B. After measurement of intrinsic membrane potential, if necessary, current was injected to maintain the membrane potential −75 ± 5 mV. All membrane potentials recorded were corrected off-line for liquid junction potential of −10 mV measured directly. Current pulses of increasing amplitude were used to test excitability in current-clamp. Input resistance was measured in voltage-clamp with 2 mV pulses. Signals were low-pass filtered at 5 kHz and sampled at 20 kHz with 16-bit resolution, using a National Instruments analog card, and custom software written in MATLAB and C (MatDAQ, Hugh Robinson, Department of Physiology, Development and Neuroscience, University of Cambridge, 1995–2013). All analyses were performed in MATLAB.

Experimental design and statistical analysis.

All experiments contain data from a minimum of three independent dissections, with an individual experiment defined as the cells derived from embryos of one mouse. Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software). All data in text are expressed as mean ± SD; graphs show mean ± SEM. Statistical analyses were performed using a two-tailed t test for comparison of two groups unless indicated otherwise, or an ANOVA for comparison of three or more groups, with details provided in the figure legends.

Results

Phosphomimetic tau spontaneously misfolds in cultured neurons

Hyperphosphorylation of tau is associated with aggregation and pathology, and phosphomimetic tau (tauE14) mislocalizes to dendritic spines and causes synaptic dysfunction (Hoover et al., 2010). To examine whether tauE14 spontaneously misfolds and forms visible aggregates, we cultured murine hippocampal neurons and transfected them at 1 DIV with fluorescently tagged human 0N4R tau: GFP-tauE14 or RFP-tauE14 and GFP-tauWT or RFP-tauWT, respectively. Expression of either tauWT or tauE14 did not adversely affect axonal outgrowth compared with control neurons (Fig. 1a), and both wild-type (data not shown) and mutant tau localized to intracellular structures (Fig. 1b). At 14 DIV, tauWT displayed a smooth and even distribution throughout the cell, including along the axon. In contrast, tauE14 expression resulted in a clustered tau distribution, particularly along distal axons (Fig. 1c,d). Using an antibody that selectively recognizes misfolded tau, MC1 (Jicha et al., 1997), we confirmed that the clustering of fluorescence reported tau misfolding within the cell. No misfolded tau was detected in axons exogenously expressing tauWT (Fig. 1d), confirming that it is not a consequence of the introduction of human tau per se. This suggests that the fluorescence accumulations in the mutant tau-expressing neurons represent either amorphous or structured buildups of misfolded tau that we refer to as aggregates. To analyze the appearance of tau aggregation we generated fluorescence distribution profiles along individual axons. This confirmed highly variable fluorescence intensities along axons of tauE14-expressing neurons, compared with a smooth fluorescence distribution in tauWT-expressing neurons (Fig. 1c). At 14 DIV, 56.0 ± 7.7% of the tauE14-expressing axons have developed aggregates, whereas the distal axons of tauWT-expressing neurons remained aggregate-free. This demonstrates that tau phosphorylation is sufficient to induce its misfolding and aggregation.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Tau aggregates spontaneously develop in GFP-tauE14-expressing hippocampal neurons. a, Hippocampal neurons were transfected with GFP, GFP-tauWT or GFP-tauE14 at 1 DIV and fixed and imaged at 7 DIV. No difference in axonal outgrowth was observed. Each data point is one axon, n ≥ 18 axons per condition from three experiments. One-way ANOVA, p = 0.98, F(2,55) = 0.017. Error bars indicate SEM. b, A higher-magnification view of a hippocampal neuron transfected with GFP-tauE14 at 1 DIV and fixed and imaged at 14 DIV. Scale bars, 10 μm. c, A line was drawn along distal axons expressing tauWT (top, magenta) or tauE14 (middle, green) to generate corresponding intensity profiles (bottom). Scale bar, 5 μm. d, TauE14 and surrounding untransfected axons (arrows), but not tauWT-expressing axons are positive for misfolded tau. Scale bar, 5 μm. ns = not significant.

Tau misfolding efficiently propagates to connected neurons

Untransfected neurites in the vicinity of a tauE14-expressing axon were positive for misfolded tau (Fig. 1d, arrows). This suggests that tauE14 expression is sufficient not only to induce misfolding and aggregation of tau within the axon, but also to generate seeds that spread to neighboring cells. To more precisely investigate the spread and propagation of tau misfolding and aggregation between neurons, we cocultured tauE14-expressing “donor” cells and tauWT “acceptor” cells within a microfluidic device that allows coculture of two spatially distinct neuronal populations that can be manipulated independently but are in contact via projecting axons (Taylor et al., 2005; J. W. Wu et al., 2013). This enabled us to separate tauE14 and tauWT-expressing neurons and identify individual connecting cells (Fig. 2a–c). Aggregates were first detected at 8 DIV in the axons of tauE14-expressing donor neurons (Fig. 2e), and the number of axons positive for tau aggregation steadily increased at a rate of 4.9 ± 0.6% per day, until a plateau was reached at 18 DIV with 75.5 ± 6.4% of axons containing visible tau aggregates (Fig. 2e). Next, we analyzed the percentage of aggregate positive acceptor neurons to assess whether propagation occurs in our system. We first detected aggregates in tauWT acceptor axons connected to tauE14-expressing donor neurons at 10 DIV, and their percentage increased over time by 4.9 ± 0.4% additional distal acceptor axons positive for tau aggregation per day (Fig. 2d,e). They thus followed the donor neurons with a delay of ∼3.7 d, until 77.5 ± 7.8% of distal axons contained tau aggregates, reaching the same plateau as donor distal axons (p > 0.999 between donor and acceptor axons at 24 and 26 DIV; Fig. 2e). No aggregation was detected when tauWT acceptor neurons were connected to GFP or GFP-tauWT-expressing control cells, demonstrating a clear difference in conformation of tauWT dependent on the type of donor cell to which it connects (p < 0.0001; Fig. 2d,e). This demonstrates that within a minimal neuronal circuit, expression of phosphomimetic tau in primary hippocampal neurons prompts tau misfolding and the generation of tau seeds, which rapidly and efficiently transfer to connected cells where they propagate aggregation of tau in a prion-like manner.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Tau misfolding efficiently propagates to connected neurons. a, Example image of donor and acceptor cells connected within microfluidic devices. Dashed lines indicate channel boundaries. Scale bar, 30 μm. b, Schematic of microfluidic device to investigate propagation from donor (tauE14; green) to acceptor (tauWT; magenta) neurons. c, Higher-magnification of white box in a showing intersections of donor axons and acceptor dendrites. Scale bar, 15 μm. d, TauWT expressing acceptor neurons form aggregates when connected to tauE14-expressing donor neurons. e, Neurons were transfected at 1 DIV and analyzed for aggregate formation. Time course of aggregate formation in axons of tauE14-expressing donor neurons (green circles), connected tauWT-expressing acceptor neurons (magenta squares), and tauWT-expressing neurons connected to control cells (orange triangles). N ≥ 12 axons per experiment, three independent experiments per time point. Two-way ANOVA with Tukey's test, F(2,60) = 851. TauE14 (green) compared with tauWT connected to tauE14 (magenta) at 24 and 26 DIV: ns, p > 0.999. TauWT connected to tauE14 (magenta) compared with tauWT connected to control (orange) at 10 DIV: **p = 0.0028; 12–26 DIV: ****p < 0.0001. Error bars indicate SEM. ns = not significant.

Distinct neuronal subcompartments display a differential vulnerability to tau misfolding and aggregation

In both the donor (data not shown) and acceptor neurons, tau aggregates first appeared in the distal axon, and were later detected in the somatodendritic compartment (Fig. 3a). For distal axonal misfolding and aggregation to occur in the acceptor neuron within the oriented setup of the microfluidic chamber (Fig. 2a,b), seeds that have been internalized at the somatodendritic compartment must have been transported to the distal axon, or alternatively, must have propagated the conformational change throughout the cell. Indeed, we detected GFP-tauE14-positive accumulations in the somata of RFP-tauWT-expressing neurons (Fig. 3b), indicating transfer of tauE14 to the connected neuron. No aggregates were visible within the somata of tauWT-expressing neurons connected to GFP-expressing cells (Fig. 3c). The aggregates within the tauWT-expressing somata were dual-positive for GFP-tauE14 and RFP-tauWT, demonstrating that the phosphomimetic tau had further recruited native tau into aggregates (Fig. 3b), thus suggesting a prion-like propagation of aggregation. We confirmed that the misfolding of tau was propagated to the distal axons of acceptor cells using MC1 staining (Fig. 3d). No GFP-tauE14 was detected in the tau accumulations of RFP-tauWT-expressing axons (data not shown); substantiating that tauE14 seeded the misfolding of tauWT. This demonstrates that as well as being sufficient for inducing tau aggregate formation, mimicking phosphorylation of tau is sufficient for the prion-like propagation of the conformational change to surrounding neurons. Interestingly, we never detected tau aggregation at the proximal axonal segment of either donor or acceptor neurons, and this axonal subcompartment also remained negative for MC1 staining indicating absence of misfolded species (Fig. 3d). Together with the observation that visible tau aggregates were first observed in the distal axon of acceptor cells, despite receiving the seeds at the somatodendritic compartment, this suggests that (1) smaller seeds distribute throughout the neuron before the formation of visible aggregates; (2) tau in the distal axon is most susceptible to aggregation; and (3) misfolded tau does not accumulate in, or is rapidly cleared from, the proximal axonal region.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Differential subcompartment vulnerability to tau misfolding. a, Acceptor somata (light gray circles) and distal axons (dark gray squares) containing tau aggregates at different time points. Each data point is the mean of one experiment, n ≥ 8 fixed cells per time point per experiment. Two-way repeated (region) -measures ANOVA, F(1,4) = 68.02, ns p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, with post hoc Sidak's multiple-comparison test. Error bars indicate SEM. b, c, Confocal microscopy shows that (b) GFP-tauE14 aggregates are detected in the somata of RFP-tauWT-expressing acceptor neurons and overlap with RFP-tauWT aggregates, whereas (c) RFP-tauWT-expressing neurons connected to GFP-expressing cells do not develop aggregates. Shown are Z-projections. Scale bars: 10 μm, imaged at 14 DIV. d, Proximal (1,3) and distal (2,4) axonal segments of tauE14 and connected tauWT-expressing neurons were counterstained for MC1 and imaged at 14 DIV. Scale bar, 5 μm. ns = not significant.

Misfolded tau is not acutely toxic

We monitored the formation and propagation of tau pathology at the single cell level, and thus were able to analyze the state of tauE14-expressing cells at the time of misfolding and active tau seed transmission and propagation of misfolding. Loss of synaptic connections has been identified as one of the earliest cellular changes in AD (Scheff et al., 1990; Masliah et al., 2001). Because tau misfolding and aggregation first occur in the distal axon, we visualized a presynaptic marker, synapsin, to assess the density of presynaptic sites in tauE14-expressing donor neurons at a time point of active tau seed propagation (14 DIV). There was no significant difference in the number of presynaptic sites between tauWT- and tauE14-expressing neurons and their untransfected surrounding axons (p = 0.82; Fig. 4a–c). In fact, the neurons appear intact and undistinguishable from surrounding untransfected cells, as judged by DIC imaging, exhibiting a smooth and intact plasma membrane and healthy nuclear morphology (Fig. 4a). This suggests that the presence and release of misfolded tau seeds are not acutely toxic to hippocampal neurons. Indeed, we did not observe disintegration or death of these neurons across the analyzed time course to 26 DIV and beyond.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Neurons transmitting tau pathology remain intact. a, b, A 14 DIV tauE14-expressing neuron. a, Overview of neuron stained with synapsin, nucleus stained with Hoechst 33342, and the DIC image showing an intact membrane at the cell body and along the axon. Scale bar, 30 μm. b, The distal axons of tauE14-expressing neurons counterstained with synapsin. Scale bar, 10 μm. c, Quantification of synapsin puncta per 20 μm stretch of axon. One-way ANOVA, F(2,6) = 0.06, p = 0.82. Each data point represents the mean of one experiment, with n = 45 axons total (untransfected, tauE14) and 35 axons total (tauWT).

We next investigated the physiological state of aggregate-containing neurons in more detail to assess the functional consequences. Because tau acts in microtubule stabilization (Drubin and Kirschner, 1986), and its dysfunction leads to axonal transport deficits (Alonso et al., 1994; Mandelkow et al., 2003), we first assessed lysosome dynamics. Lysosomes are transported bidirectionally along axons (Che et al., 2016). At 14 DIV there was a significant decrease in the number of lysosomes present at the distal axon of tauE14-expressing neurons compared with tauWT controls (p = 0.0017; Fig. 5a,b). Of those lysosomes present, a significantly lower percentage were moving within tauE14 axons (21.1 ± 3.9%) compared with tauWT controls (45.8 ± 5.8%, p = 0.0036; Fig. 5c–e), confirming an early axonal transport dysfunction in the presence of tau misfolding.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

TauE14-expressing neurons show selective axonal dysfunctions at 14 DIV. Imaging of lysosomes at the distal axon reveals (a, b) a reduction in the number of lysosomes (white arrows) in tauE14-expressing distal axons compared with tauWT-expressing cells. N = 8 cells per experiment, each point is the mean of one experiment. t test, df = 4, t = 7.44, p = 0.0017. c–e, Analysis of lysosome dynamics in tauE14 and tauWT-expressing axons. c, d, Representative kymographs of tauWT and tauE14-expressing axons. e, Transport analysis of lysosomes. Each data point is the mean of one experiment; n ≥ 8 cells per experiment. Error bars indicate SEM. One-tailed t test, df = 4, t = 6.14, p = 0.0018. **p < 0.01.

To confirm our observation that neurons-expressing tauE14 remained viable in the presence of misfolded tau we then visualized spontaneous activity using calcium imaging (Fig. 6a,b). Both tauWT- and tauE14-expressing neurons displayed calcium fluxes that were sensitive to tetrodotoxin, showing that they were driven by voltage-gated sodium channels. This demonstrates that energy-dependent processes were functional and suggests that neurons remain electrically competent in the presence of misfolded and aggregated tau. To investigate the electrical competence in more detail we performed electrophysiological analysis on the cells with whole-cell patch-clamp. Both tauE14- and tauWT-expressing neurons were capable of responding to positive current injections with action potentials of a similar amplitude (Fig. 6c). There were no significant differences in the minimum current required to evoke a single action potential (rheobase); with tauE14- and tauWT-expressing neurons requiring 77 ± 40 pA and 83 ± 25 pA respectively (p = 0.82; Fig. 6d). We further found no significant differences in the input resistance between tauE14 (694 ± 367 MΩ) and tauWT (578 ± 101 MΩ) -expressing cells (p = 0.62; Fig. 6e), and the resting membrane potentials of tauE14 (−73.8 ± 2.4 mV) and tauWT (−73.3 ± 3.5 mV) -expressing neurons did not differ (p = 0.85; Fig. 6f). This shows that despite possessing and transmitting tau pathology, donor neurons maintain a normal resting membrane potential and fire action potentials to the same extent as tauWT control neurons.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

TauE14 neurons are electrically competent. Basal calcium activity of a 14 DIV (a) tauWT (b) and tauE14-expressing neuron, which is silenced on application of 1 μm TTX. Addition of 100 mm KCl confirms viability at the end of acquisition. c–f, Electrophysiology on 14 DIV neurons. c, Sample traces of current injection into patch-clamped neurons. d, Rheobase of tauWT and tauE14-expressing neurons show a similar minimal current is required for action potential initiation. t test, df = 4, t = 0.24, p = 0.82. e, Input resistance of tauWT and tauE14-expressing neurons shows no significant difference. t test, df = 4, t = 0.53, p = 0.62. f, Resting membrane potentials recorded for tauWT and tauE14-expressing neurons. t test, df = 4, t = 0.20, p = 0.85. d–f, N ≥ 3 cells per experiment, each point = median of one experiment. ns = not significant.

Together, these data demonstrate that phosphomimetic tau misfolds and aggregates in the absence of exogenous seeds, and that transmission of tau misfolding to healthy neurons is an active and efficient process that is accompanied by selective neuronal dysfunction. The presence of misfolded and aggregated tau does not compromise neuronal excitability and is compatible with longer-term neuronal viability.

Discussion

What triggers the initial tau seed formation in vivo is unclear, and there is currently a debate as to the nature of this propagative species (Michel et al., 2014; Mirbaha et al., 2015; Sharma et al., 2018). The presence of mutations increases the propensity of seed formation (Gao et al., 2018), and tau aggregation is associated with hyperphosphorylation (Alonso et al., 1996; Wang et al., 1996, 2007). Indeed, AD is associated with an imbalance of kinase and phosphatase activities (Stoothoff and Johnson, 2005) that leads to hyperphosphorylation of tau, detectable within NFTs (Hanger et al., 2009). We here show that the negative charges conferred by a phosphomimetic tau, which simulates hyperphosphorylation at 14 disease-related sites, do not interfere with localization to subcellular structures, but are sufficient to initiate tau misfolding and aggregation within a living neuron in the absence of exogenous seeds. Previous work showed that when using recombinant seeds, the efficiency of seeding is decreased in the presence of hyperphosphorylation (Falcon et al., 2015), and tau seeds isolated from tgP301S tau mouse brains more potently seed misfolding than tau seeds formed in vitro. This increased potency of tgP301S seeds is retained upon amplification with recombinantly generated tau protein that is not post-translationally modified (Falcon et al., 2015). Together with our data, this suggests that hyperphosphorylation itself does not interfere with subcellular tau localization nor dictate misfolding. However, within a cellular environment the negative charges associated with hyperphosphorylation increase the propensity for folding into an alternative structure that can act as an efficient seed for native tau to misfold, aggregate, and propagate.

The compartmented setup of the device propagation assay allowed us to monitor individual neurons that formed or received misfolded tau species. This allowed for the first time, an analysis of propagation efficiency, and showed unexpectedly fast and robust tau propagation from neuron to neuron in vitro with a near complete transmission efficiency. Our study used pure murine hippocampal neurons, cultured in the absence of other cell types. The high efficiency of transmission may be because of a lack of a glial population, which display tau pathology in patients with tauopathy (Spillantini et al., 1997, 1998; Arai et al., 2001), as well as in in vivo (Clavaguera et al., 2013) and in vitro (Bolós et al., 2016) models of tauopathy. Therefore, glial populations may play a role in clearance of secreted pathogenic tau, and their absence in our setup revealed an under-appreciated intrinsic high efficiency of tau release and re-uptake in neurons. Synaptic contacts have been shown to enhance tau propagation in vitro (Calafate et al., 2015; Wang et al., 2017), however, our system shows tau propagation at earlier time points than mature synapse formation (Ichikawa et al., 1993), and no increased rate of propagation after this time point. This high efficiency of neuron-to-neuron tau propagation suggests that a physiological process of protein transmission may be at play, which is occurring in healthy neurons but only revealed under pathological conditions through transmission of a conformationally altered species. This idea is reinforced by the observation that healthy tau is secreted from intact neurons in an activity-dependent manner (Pooler et al., 2013). The rapid and efficient propagation of tau misfolding in our system is at odds with findings that show Braak staging progresses in patients over a matter of years to decades (Braak et al., 2011). This staging measures the presence of NFTs, which are highly structured end-stage tau assemblies within dead or dying neuronal cells. The discrepancy may thus result from the fact that we measured early events of tau misfolding in response to exogenously expressed mutant tau. The timing with which initial misfolding of tau converts to cellular degeneration, tangle formation, and cytotoxicity remains unclear. The connected compartmentalized setup used in this study allows direct investigation of individual neurons that initiate and propagate misfolding, or that receive transmitted tau seeds, at single-cell and subcellular levels. This revealed compartmentalized tau aggregation within individual neurons that begins within the distal axon, regardless of whether misfolding was originally initiated within the cell or transmitted to it. This spatial organization holds true despite the oriented setup of connected neurons, where tau seeds first enter the receiving neurons at the somatodendritic region: the site furthest from the distal axon where aggregation is initiated. Only later were aggregates visible within the somata. This confirms that the in vitro setup faithfully replicates in vivo observations describing pathological tau present in axonal tracts before its appearance in the somatodendritic compartment (Christensen et al., 2019), and before the neuropil threads seen in advanced AD (Braak et al., 1986). Furthermore, we did not observe tau aggregates in the proximal axonal segment, even at stages where clear aggregates were visible in both the soma and distal axon. This suggests either a selective vulnerability of the distal axonal segment, or protection against tau misfolding in proximal axonal regions. The axon initial segment has been shown to act as a barrier for select isoforms of tau proteins, potentially because of increased microtubule dynamics in this area (Sohn et al., 2016; Zempel et al., 2017), which may play a role in the lack of retention of misfolded tau within this region. However, it is clear from our data that misfolded tau is able to cross this barrier and cause distal axon pathology.

In vivo paradigms do not yet facilitate the direct visualization of neurons that are actively releasing and propagating tau pathology. Monitoring tau misfolding and aggregation within single cells allowed us to directly assess the physiological effects that tau misfolding has on neurons. We found that despite containing and propagating misfolded tau for prolonged periods of time, neurons remained alive, functional, and retained energy dependent processes, yet displayed a selective dysfunction in axonal transport. Previous studies showed that acutely added tau seeds can induce toxicity and cell death via calcium dysregulation (Gómez-Ramos et al., 2006; Kopeikina et al., 2012; Tian et al., 2013). However, we found that neurons containing self-generated tau aggregates had intact calcium fluxes, physiological resting membrane potentials, were able to elicit action potentials and remained viable for extended periods of time after initial tau misfolding, aggregate formation, and propagation. Our data therefore shows that misfolded tau and tau aggregates are not themselves lethal to neurons. Instead, they initiate a selective axonal transport dysfunction that precedes synaptic loss, and in isolation does not result in axonal degeneration or cell death. Furthermore, this compartmentalized assay provides the first direct evidence showing that tau pathology propagation can occur between live and functioning cells and precedes synaptic or neuronal degeneration. Interestingly, prion seeds are detected throughout all brain regions in mice infected with prion disease, whereas degeneration is region specific (Alibhai et al., 2016). Together, these data and our findings suggest that the idea that the presence of misfolded protein in isolation does not determine neurodegeneration (Alibhai et al., 2016) may hold true across different protein misfolding diseases. Combined with a potential physiological transmission of tau between neurons, this raises the possibility that at the stage of diagnosis, tau seeds may have spread throughout wider brain regions, having passed the time point where a sequestration of free tau seeds in isolation is effective in halting disease progression. However, our data imply that because the affected neurons are intact and viable at the early stages of tau misfolding, neurons containing early tau pathology could potentially be rescued.

Footnotes

  • This work was supported by Alzheimer's Research UK (Grants ARUK-PhD2014-10 and ARUK-PPG2017B-001) and the Biotechnology and Biological Sciences Research Council (BB/L007576/1). We thank Vincent O'Connor, Dr. Amrit Mudher, and Aleksandra Pitera for critically reading the paper.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Katrin Deinhardt at K.Deinhardt{at}soton.ac.uk

References

  1. ↵
    1. Ahmed Z,
    2. Cooper J,
    3. Murray TK,
    4. Garn K,
    5. McNaughton E,
    6. Clarke H,
    7. Parhizkar S,
    8. Ward MA,
    9. Cavallini A,
    10. Jackson S,
    11. Bose S,
    12. Clavaguera F,
    13. Tolnay M,
    14. Lavenir I,
    15. Goedert M,
    16. Hutton ML,
    17. O'Neill MJ
    (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667–683. doi:10.1007/s00401-014-1254-6 pmid:24531916
    OpenUrlCrossRefPubMed
  2. ↵
    1. Alibhai J,
    2. Blanco RA,
    3. Barria MA,
    4. Piccardo P,
    5. Caughey B,
    6. Perry VH,
    7. Freeman TC,
    8. Manson JC
    (2016) Distribution of misfolded prion protein seeding activity alone does not predict regions of neurodegeneration bates. PLoS Biol 14:e1002579. doi:10.1371/journal.pbio.1002579 pmid:27880767
    OpenUrlCrossRefPubMed
  3. ↵
    1. Alonso AC,
    2. Zaidi T,
    3. Grundke-Iqbal I,
    4. Iqbal K
    (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A 91:5562–5566. doi:10.1073/pnas.91.12.5562 pmid:8202528
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Alonso AC,
    2. Grundke-Iqbal I,
    3. Iqbal K
    (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783–787. doi:10.1038/nm0796-783 pmid:8673924
    OpenUrlCrossRefPubMed
  5. ↵
    1. Alonso AC,
    2. Li B,
    3. Grundke-Iqbal I,
    4. Iqbal K
    (2006) Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc Natl Acad Sci U S A 103:8864–8869. doi:10.1073/pnas.0603214103 pmid:16735465
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Arai T,
    2. Ikeda K,
    3. Akiyama H,
    4. Shikamoto Y,
    5. Tsuchiya K,
    6. Yagishita S,
    7. Beach T,
    8. Rogers J,
    9. Schwab C,
    10. McGeer PL
    (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101:167–173. doi:10.1007/s004010000283 pmid:11271372
    OpenUrlCrossRefPubMed
  7. ↵
    1. Bolós M,
    2. Llorens-Martín M,
    3. Jurado-Arjona J,
    4. Hernández F,
    5. Rábano A,
    6. Avila J
    (2016) Direct evidence of internalization of tau by microglia in vitro and in vivo. J Alzheimers Dis 50:77–87. doi:10.3233/JAD-150704 pmid:26638867
    OpenUrlCrossRefPubMed
  8. ↵
    1. Braak H,
    2. Braak E
    (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259. doi:10.1007/BF00308809 pmid:1759558
    OpenUrlCrossRefPubMed
  9. ↵
    1. Braak H,
    2. Braak E,
    3. Grundke-Iqbal I,
    4. Iqbal K
    (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65:351–355. doi:10.1016/0304-3940(86)90288-0 pmid:2423928
    OpenUrlCrossRefPubMed
  10. ↵
    1. Braak H,
    2. Thal DR,
    3. Ghebremedhin E,
    4. Del Tredici K
    (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969. doi:10.1097/NEN.0b013e318232a379 pmid:22002422
    OpenUrlCrossRefPubMed
  11. ↵
    1. Calafate S,
    2. Buist A,
    3. Miskiewicz K,
    4. Vijayan V,
    5. Daneels G,
    6. de Strooper B,
    7. de Wit J,
    8. Verstreken P,
    9. Moechars D
    (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11:1176–1183. doi:10.1016/j.celrep.2015.04.043 pmid:25981034
    OpenUrlCrossRefPubMed
  12. ↵
    1. Che DL,
    2. Chowdary PD,
    3. Cui B
    (2016) A close look at axonal transport: cargos slow down when crossing stationary organelles. Neurosci Lett 610:110–116. doi:10.1016/j.neulet.2015.10.066 pmid:26528790
    OpenUrlCrossRefPubMed
  13. ↵
    1. Chen TW,
    2. Wardill TJ,
    3. Sun Y,
    4. Pulver SR,
    5. Renninger SL,
    6. Baohan A,
    7. Schreiter ER,
    8. Kerr RA,
    9. Orger MB,
    10. Jayaraman V,
    11. Looger LL,
    12. Svoboda K,
    13. Kim DS
    (2013) Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499:295–300. doi:10.1038/nature12354 pmid:23868258
    OpenUrlCrossRefPubMed
  14. ↵
    1. Christensen KR,
    2. Beach TG,
    3. Serrano GE,
    4. Kanaan NM
    (2019) Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways. Acta Neuropathol Commun 7:29. doi:10.1186/s40478-019-0675-9 pmid:30819250
    OpenUrlCrossRefPubMed
  15. ↵
    1. Clavaguera F,
    2. Bolmont T,
    3. Crowther RA,
    4. Abramowski D,
    5. Frank S,
    6. Probst A,
    7. Fraser G,
    8. Stalder AK,
    9. Beibel M,
    10. Staufenbiel M,
    11. Jucker M,
    12. Goedert M,
    13. Tolnay M
    (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913. doi:10.1038/ncb1901 pmid:19503072
    OpenUrlCrossRefPubMed
  16. ↵
    1. Clavaguera F,
    2. Akatsu H,
    3. Fraser G,
    4. Crowther RA,
    5. Frank S,
    6. Hench J,
    7. Probst A,
    8. Winkler DT,
    9. Reichwald J,
    10. Staufenbiel M,
    11. Ghetti B,
    12. Goedert M,
    13. Tolnay M
    (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A 110:9535–9540. doi:10.1073/pnas.1301175110 pmid:23690619
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. de Calignon A,
    2. Polydoro M,
    3. Suárez-Calvet M,
    4. William C,
    5. Adamowicz DH,
    6. Kopeikina KJ,
    7. Pitstick R,
    8. Sahara N,
    9. Ashe KH,
    10. Carlson GA,
    11. Spires-Jones TL,
    12. Hyman BT
    (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73:685–697. doi:10.1016/j.neuron.2011.11.033 pmid:22365544
    OpenUrlCrossRefPubMed
  18. ↵
    1. Deinhardt K,
    2. Kim T,
    3. Spellman DS,
    4. Mains RE,
    5. Eipper BA,
    6. Neubert TA,
    7. Chao MV,
    8. Hempstead BL
    (2011) Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac. Sci Signal 4:ra82. pmid:22155786
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. DeVos SL,
    2. Corjuc BT,
    3. Oakley DH,
    4. Nobuhara CK,
    5. Bannon RN,
    6. Chase A,
    7. Commins C,
    8. Gonzalez JA,
    9. Dooley PM,
    10. Frosch MP,
    11. Hyman BT
    (2018) Synaptic tau seeding precedes tau pathology in human Alzheimer's disease brain. Front Neurosci 12:267. doi:10.3389/fnins.2018.00267 pmid:29740275
    OpenUrlCrossRefPubMed
  20. ↵
    1. Dinh ND,
    2. Chiang YY,
    3. Hardelauf H,
    4. Baumann J,
    5. Jackson E,
    6. Waide S,
    7. Sisnaiske J,
    8. Frimat JP,
    9. van Thriel C,
    10. Janasek D,
    11. Peyrin JM,
    12. West J
    (2013) Microfluidic construction of minimalistic neuronal co-cultures. Lab Chip 13:1402–1412. doi:10.1039/c3lc41224e pmid:23403713
    OpenUrlCrossRefPubMed
  21. ↵
    1. Drubin DG,
    2. Kirschner MW
    (1986) Tau protein function in living cells. J Cell Biol 103:2739–2746. doi:10.1083/jcb.103.6.2739 pmid:3098742
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Falcon B,
    2. Cavallini A,
    3. Angers R,
    4. Glover S,
    5. Murray TK,
    6. Barnham L,
    7. Jackson S,
    8. O'Neill MJ,
    9. Isaacs AM,
    10. Hutton ML,
    11. Szekeres PG,
    12. Goedert M,
    13. Bose S
    (2015) Conformation determines the seeding potencies of native and recombinant tau aggregates. J Biol Chem 290:1049–1065. doi:10.1074/jbc.M114.589309 pmid:25406315
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Frost B,
    2. Jacks RL,
    3. Diamond MI
    (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845–12852. doi:10.1074/jbc.M808759200 pmid:19282288
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Gao YL,
    2. Wang N,
    3. Sun FR,
    4. Cao XP,
    5. Zhang W,
    6. Yu JT
    (2018) Tau in neurodegenerative disease. Ann Transl Med 6:175. doi:10.21037/atm.2018.04.23 pmid:29951497
    OpenUrlCrossRefPubMed
  25. ↵
    1. Gómez-Ramos A,
    2. Díaz-Hernández M,
    3. Cuadros R,
    4. Hernández F,
    5. Avila J
    (2006) Extracellular tau is toxic to neuronal cells. FEBS Lett 580:4842–4850. doi:10.1016/j.febslet.2006.07.078 pmid:16914144
    OpenUrlCrossRefPubMed
  26. ↵
    1. Grundke-Iqbal I,
    2. Iqbal K,
    3. Tung YC,
    4. Quinlan M,
    5. Wisniewski HM,
    6. Binder LI
    (1986) Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913–4917. doi:10.1073/pnas.83.13.4913 pmid:3088567
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Guo JL,
    2. Lee VM
    (2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286:15317–15331. doi:10.1074/jbc.M110.209296 pmid:21372138
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Hanger DP,
    2. Anderton BH,
    3. Noble W
    (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112–119. doi:10.1016/j.molmed.2009.01.003 pmid:19246243
    OpenUrlCrossRefPubMed
  29. ↵
    1. Holloway PM,
    2. Hallinan GI,
    3. Hegde M,
    4. Lane SIR,
    5. Deinhardt K,
    6. West J
    (2019) Asymmetric confinement for defining outgrowth directionality. Lab Chip 19:1484–1489. doi:10.1039/C9LC00078J pmid:30899932
    OpenUrlCrossRefPubMed
  30. ↵
    1. Hoover BR,
    2. Reed MN,
    3. Su J,
    4. Penrod RD,
    5. Kotilinek LA,
    6. Grant MK,
    7. Pitstick R,
    8. Carlson GA,
    9. Lanier LM,
    10. Yuan LL,
    11. Ashe KH,
    12. Liao D
    (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067–1081. doi:10.1016/j.neuron.2010.11.030 pmid:21172610
    OpenUrlCrossRefPubMed
  31. ↵
    1. Hu W,
    2. Zhang X,
    3. Tung YC,
    4. Xie S,
    5. Liu F,
    6. Iqbal K
    (2016) Hyperphosphorylation determines both the spread and the morphology of tau pathology. Alzheimers Dement 12:1066–1077. doi:10.1016/j.jalz.2016.01.014 pmid:27133892
    OpenUrlCrossRefPubMed
  32. ↵
    1. Ichikawa M,
    2. Muramoto K,
    3. Kobayashi K,
    4. Kawahara M,
    5. Kuroda Y
    (1993) Formation and maturation of synapses in primary cultures of rat cerebral cortical cells: an electron microscopic study. Neurosci Res 16:95–103. doi:10.1016/0168-0102(93)90076-3 pmid:8387174
    OpenUrlCrossRefPubMed
  33. ↵
    1. Jackson SJ,
    2. Kerridge C,
    3. Cooper J,
    4. Cavallini A,
    5. Falcon B,
    6. Cella CV,
    7. Landi A,
    8. Szekeres PG,
    9. Murray TK,
    10. Ahmed Z,
    11. Goedert M,
    12. Hutton M,
    13. O'Neill MJ,
    14. Bose S
    (2016) Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau. J Neurosci 36:762–772. doi:10.1523/JNEUROSCI.3542-15.2016 pmid:26791207
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Jicha GA,
    2. Bowser R,
    3. Kazam IG,
    4. Davies P
    (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128–132. doi:10.1002/(SICI)1097-4547(19970415)48:2%3C128::AID-JNR5%3E3.0.CO;2-E pmid:9130141
    OpenUrlCrossRefPubMed
  35. ↵
    1. Kaufman SK,
    2. Sanders DW,
    3. Thomas TL,
    4. Ruchinskas AJ,
    5. Vaquer-Alicea J,
    6. Sharma AM,
    7. Miller TM,
    8. Diamond MI
    (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92:796–812. doi:10.1016/j.neuron.2016.09.055 pmid:27974162
    OpenUrlCrossRefPubMed
  36. ↵
    1. Kfoury N,
    2. Holmes BB,
    3. Jiang H,
    4. Holtzman DM,
    5. Diamond MI
    (2012) Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287:19440–19451. doi:10.1074/jbc.M112.346072 pmid:22461630
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Kim D,
    2. Lim S,
    3. Haque MM,
    4. Ryoo N,
    5. Hong HS,
    6. Rhim H,
    7. Lee DE,
    8. Chang YT,
    9. Lee JS,
    10. Cheong E,
    11. Kim DJ,
    12. Kim YK
    (2015) Identification of disulfide cross-linked tau dimer responsible for tau propagation. Sci Rep 5:15231. doi:10.1038/srep15231 pmid:26470054
    OpenUrlCrossRefPubMed
  38. ↵
    1. Kopeikina KJ,
    2. Hyman BT,
    3. Spires-Jones TL
    (2012) Soluble forms of tau are toxic in Alzheimer's disease. Transl Neurosci 3:223–233. doi:10.2478/s13380-012-0032-y pmid:23029602
    OpenUrlCrossRefPubMed
  39. ↵
    1. Köpke E,
    2. Tung YC,
    3. Shaikh S,
    4. Alonso AC,
    5. Iqbal K,
    6. Grundke-Iqbal I
    (1993) Microtubule-associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374–24384. pmid:8226987
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Lasagna-Reeves CA,
    2. Castillo-Carranza DL,
    3. Sengupta U,
    4. Guerrero-Munoz MJ,
    5. Kiritoshi T,
    6. Neugebauer V,
    7. Jackson GR,
    8. Kayed R
    (2012) Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep 2:700. doi:10.1038/srep00700 pmid:23050084
    OpenUrlCrossRefPubMed
  41. ↵
    1. Li B,
    2. Chohan MO,
    3. Grundke-Iqbal I,
    4. Iqbal K
    (2007) Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113:501–511. doi:10.1007/s00401-007-0207-8 pmid:17372746
    OpenUrlCrossRefPubMed
  42. ↵
    1. Liu L,
    2. Drouet V,
    3. Wu JW,
    4. Witter MP,
    5. Small SA,
    6. Clelland C,
    7. Duff K
    (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7:e31302. doi:10.1371/journal.pone.0031302 pmid:22312444
    OpenUrlCrossRefPubMed
  43. ↵
    1. Mandelkow EM,
    2. Stamer K,
    3. Vogel R,
    4. Thies E,
    5. Mandelkow E
    (2003) Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24:1079–1085. doi:10.1016/j.neurobiolaging.2003.04.007 pmid:14643379
    OpenUrlCrossRefPubMed
  44. ↵
    1. Masliah E,
    2. Mallory M,
    3. Alford M,
    4. DeTeresa R,
    5. Hansen LA,
    6. McKeel DW Jr.,
    7. Morris JC
    (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56:127–129. doi:10.1212/WNL.56.1.127 pmid:11148253
    OpenUrlCrossRefPubMed
  45. ↵
    1. Meijering E,
    2. Jacob M,
    3. Sarria JC,
    4. Steiner P,
    5. Hirling H,
    6. Unser M
    (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry 58:167–176. doi:10.1002/cyto.a.20022 pmid:15057970
    OpenUrlCrossRefPubMed
  46. ↵
    1. Michel CH,
    2. Kumar S,
    3. Pinotsi D,
    4. Tunnacliffe A,
    5. St George-Hyslop P,
    6. Mandelkow E,
    7. Mandelkow EM,
    8. Kaminski CF,
    9. Kaminski Schierle GS
    (2014) Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology. J Biol Chem 289:956–967. doi:10.1074/jbc.M113.515445 pmid:24235150
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Mirbaha H,
    2. Holmes BB,
    3. Sanders DW,
    4. Bieschke J,
    5. Diamond MI
    (2015) Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation. J Biol Chem 290:14893–14903. doi:10.1074/jbc.M115.652693 pmid:25887395
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Nobuhara CK,
    2. DeVos SL,
    3. Commins C,
    4. Wegmann S,
    5. Moore BD,
    6. Roe AD,
    7. Costantino I,
    8. Frosch MP,
    9. Pitstick R,
    10. Carlson GA,
    11. Hock C,
    12. Nitsch RM,
    13. Montrasio F,
    14. Grimm J,
    15. Cheung AE,
    16. Dunah AW,
    17. Wittmann M,
    18. Bussiere T,
    19. Weinreb PH,
    20. Hyman BT, et al
    . (2017) Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of tau in vitro. Am J Pathol 187:1399–1412. doi:10.1016/j.ajpath.2017.01.022 pmid:28408124
    OpenUrlCrossRefPubMed
  49. ↵
    1. Peyrin JM,
    2. Deleglise B,
    3. Saias L,
    4. Vignes M,
    5. Gougis P,
    6. Magnifico S,
    7. Betuing S,
    8. Pietri M,
    9. Caboche J,
    10. Vanhoutte P,
    11. Viovy JL,
    12. Brugg B
    (2011) Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. Lab Chip 11:3663–3673. doi:10.1039/c1lc20014c pmid:21922081
    OpenUrlCrossRefPubMed
  50. ↵
    1. Pickett EK,
    2. Henstridge CM,
    3. Allison E,
    4. Pitstick R,
    5. Pooler A,
    6. Wegmann S,
    7. Carlson G,
    8. Hyman BT,
    9. Spires-Jones TL
    (2017) Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease. Synapse 71:e21965. doi:10.1002/syn.21965 pmid:28196395
    OpenUrlCrossRefPubMed
  51. ↵
    1. Pooler AM,
    2. Phillips EC,
    3. Lau DH,
    4. Noble W,
    5. Hanger DP
    (2013) Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14:389–394. doi:10.1038/embor.2013.15 pmid:23412472
    OpenUrlCrossRefPubMed
  52. ↵
    1. Sanders DW,
    2. Kaufman SK,
    3. DeVos SL,
    4. Sharma AM,
    5. Mirbaha H,
    6. Li A,
    7. Barker SJ,
    8. Foley AC,
    9. Thorpe JR,
    10. Serpell LC,
    11. Miller TM,
    12. Grinberg LT,
    13. Seeley WW,
    14. Diamond MI
    (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271–1288. doi:10.1016/j.neuron.2014.04.047 pmid:24857020
    OpenUrlCrossRefPubMed
  53. ↵
    1. Scheff SW,
    2. DeKosky ST,
    3. Price DA
    (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11:29–37. doi:10.1016/0197-4580(90)90059-9 pmid:2325814
    OpenUrlCrossRefPubMed
  54. ↵
    1. Sharma AM,
    2. Thomas TL,
    3. Woodard DR,
    4. Kashmer OM,
    5. Diamond MI
    (2018) Tau monomer encodes strains. eLife 7:e37813. doi:10.7554/eLife.37813 pmid:30526844
    OpenUrlCrossRefPubMed
  55. ↵
    1. Sohn PD,
    2. Tracy TE,
    3. Son HI,
    4. Zhou Y,
    5. Leite RE,
    6. Miller BL,
    7. Seeley WW,
    8. Grinberg LT,
    9. Gan L
    (2016) Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol Neurodegener 11:47. doi:10.1186/s13024-016-0109-0 pmid:27356871
    OpenUrlCrossRefPubMed
  56. ↵
    1. Spillantini MG,
    2. Goedert M,
    3. Crowther RA,
    4. Murrell JR,
    5. Farlow MR,
    6. Ghetti B
    (1997) Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A 94:4113–4118. doi:10.1073/pnas.94.8.4113 pmid:9108114
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Spillantini MG,
    2. Crowther RA,
    3. Kamphorst W,
    4. Heutink P,
    5. van Swieten JC
    (1998) Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 153:1359–1363. doi:10.1016/S0002-9440(10)65721-5 pmid:9811325
    OpenUrlCrossRefPubMed
  58. ↵
    1. Stoothoff WH,
    2. Johnson GV
    (2005) Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 1739:280–297. doi:10.1016/j.bbadis.2004.06.017 pmid:15615646
    OpenUrlCrossRefPubMed
  59. ↵
    1. Takeda S,
    2. Wegmann S,
    3. Cho H,
    4. DeVos SL,
    5. Commins C,
    6. Roe AD,
    7. Nicholls SB,
    8. Carlson GA,
    9. Pitstick R,
    10. Nobuhara CK,
    11. Costantino I,
    12. Frosch MP,
    13. Müller DJ,
    14. Irimia D,
    15. Hyman BT
    (2015) Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain. Nat Commun 6:8490. doi:10.1038/ncomms9490 pmid:26458742
    OpenUrlCrossRefPubMed
  60. ↵
    1. Taylor AM,
    2. Rhee SW,
    3. Tu CH,
    4. Cribbs DH,
    5. Cotman CW,
    6. Jeon NL
    (2003) Microfluidic multicompartment device for neuroscience research. Langmuir 19:1551–1556. doi:10.1021/la026417v pmid:20725530
    OpenUrlCrossRefPubMed
  61. ↵
    1. Taylor AM,
    2. Blurton-Jones M,
    3. Rhee SW,
    4. Cribbs DH,
    5. Cotman CW,
    6. Jeon NL
    (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2:599–605. doi:10.1038/nmeth777 pmid:16094385
    OpenUrlCrossRefPubMed
  62. ↵
    1. Tian H,
    2. Davidowitz E,
    3. Lopez P,
    4. Emadi S,
    5. Moe J,
    6. Sierks M
    (2013) Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations. Int J Cell Biol 2013:260787. doi:10.1155/2013/260787 pmid:24159335
    OpenUrlCrossRefPubMed
  63. ↵
    1. Wang JZ,
    2. Grundke-Iqbal I,
    3. Iqbal K
    (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 38:200–208. doi:10.1016/0169-328X(95)00316-K pmid:8793108
    OpenUrlCrossRefPubMed
  64. ↵
    1. Wang JZ,
    2. Grundke-Iqbal I,
    3. Iqbal K
    (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25:59–68. doi:10.1111/j.1460-9568.2006.05226.x pmid:17241267
    OpenUrlCrossRefPubMed
  65. ↵
    1. Wang Y,
    2. Balaji V,
    3. Kaniyappan S,
    4. Krüger L,
    5. Irsen S,
    6. Tepper K,
    7. Chandupatla R,
    8. Maetzler W,
    9. Schneider A,
    10. Mandelkow E,
    11. Mandelkow EM
    (2017) The release and trans-synaptic transmission of tau via exosomes. Mol Neurodegener 12:5. doi:10.1186/s13024-016-0143-y pmid:28086931
    OpenUrlCrossRefPubMed
  66. ↵
    1. Wu JW,
    2. Herman M,
    3. Liu L,
    4. Simoes S,
    5. Acker CM,
    6. Figueroa H,
    7. Steinberg JI,
    8. Margittai M,
    9. Kayed R,
    10. Zurzolo C,
    11. Di Paolo G,
    12. Duff KE
    (2013) Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 288:1856–1870. doi:10.1074/jbc.M112.394528 pmid:23188818
    OpenUrlAbstract/FREE Full Text
  67. ↵
    1. Wu JW,
    2. Hussaini SA,
    3. Bastille IM,
    4. Rodriguez GA,
    5. Mrejeru A,
    6. Rilett K,
    7. Sanders DW,
    8. Cook C,
    9. Fu H,
    10. Boonen RA,
    11. Herman M,
    12. Nahmani E,
    13. Emrani S,
    14. Figueroa YH,
    15. Diamond MI,
    16. Clelland CL,
    17. Wray S,
    18. Duff KE
    (2016) Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 19:1085–1092. doi:10.1038/nn.4328 pmid:27322420
    OpenUrlCrossRefPubMed
  68. ↵
    1. Wu J,
    2. Liu L,
    3. Matsuda T,
    4. Zhao Y,
    5. Rebane A,
    6. Drobizhev M,
    7. Chang YF,
    8. Araki S,
    9. Arai Y,
    10. March K,
    11. Hughes TE,
    12. Sagou K,
    13. Miyata T,
    14. Nagai T,
    15. Li WH,
    16. Campbell RE
    (2013) Improved orange and red Ca2± indicators and photophysical considerations for optogenetic applications. ACS Chem Neurosci 4:963–972. doi:10.1021/cn400012b pmid:23452507
    OpenUrlCrossRefPubMed
  69. ↵
    1. Zempel H,
    2. Dennissen FJA,
    3. Kumar Y,
    4. Luedtke J,
    5. Biernat J,
    6. Mandelkow EM,
    7. Mandelkow E
    (2017) Axodendritic sorting and pathological missorting of tau are isoform-specific and determined by axon initial segment architecture. J Biol Chem 292:12192–12207. doi:10.1074/jbc.M117.784702 pmid:28536263
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

The Journal of Neuroscience: 39 (48)
Journal of Neuroscience
Vol. 39, Issue 48
27 Nov 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons
Grace I. Hallinan, Mariana Vargas-Caballero, Jonathan West, Katrin Deinhardt
Journal of Neuroscience 27 November 2019, 39 (48) 9623-9632; DOI: 10.1523/JNEUROSCI.1590-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons
Grace I. Hallinan, Mariana Vargas-Caballero, Jonathan West, Katrin Deinhardt
Journal of Neuroscience 27 November 2019, 39 (48) 9623-9632; DOI: 10.1523/JNEUROSCI.1590-19.2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Alzheimer's disease
  • microfluidic devices
  • prion-like propagation
  • seeding
  • tau

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Irrelevant Threats Linger and Affect Behavior in High Anxiety
  • Spatiotemporal Developmental Gradient of Thalamic Morphology, Microstructure, and Connectivity fromthe Third Trimester to Early Infancy
  • Expression of a Form of Cerebellar Motor Memory Requires Learned Alterations to the Activity of Inhibitory Molecular Layer Interneurons
Show more Research Articles

Neurobiology of Disease

  • Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease
  • Activation of PPARα exhibits therapeutic efficacy in a mouse model of juvenile neuronal ceroid lipofuscinosis
  • Peroxynitrite contributes to behavioral responses, increased trigeminal excitability, and changes in mitochondrial function in a preclinical model of migraine
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.